Column Capital Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$258K Sell
1,733
-7
-0.4% -$1.03K 0.04% 121
2023
Q2
$235K Sell
1,740
-12
-0.7% -$1.76K 0.03% 127
2023
Q1
$279K Buy
1,752
+4
+0.2% +$612 0.04% 109
2022
Q4
$282K Buy
1,748
+5
+0.3% +$767 0.05% 95
2022
Q3
$234K Buy
1,743
+4
+0.2% +$574 0.05% 101
2022
Q2
$266K Buy
1,739
+4
+0.2% +$611 0.05% 89
2022
Q1
$281K Sell
1,735
-706
-29% -$103K 0.05% 105
2021
Q4
$330K Buy
2,441
+684
+39% +$80.8K 0.06% 94
2021
Q3
$190K Sell
1,757
-9
-0.5% -$1.03K 0.04% 127
2021
Q2
$199K Buy
1,766
+420
+31% +$47.3K 0.04% 120
2021
Q1
$146K Sell
1,346
-37
-3% -$3.96K 0.03% 142
2020
Q4
$148K Sell
1,383
-159
-10% -$15.3K 0.04% 133
2020
Q3
$135K Buy
1,542
+254
+20% +$23.9K 0.04% 128
2020
Q2
$126K Hold
1,288
0.04% 129
2020
Q1
$98K Sell
1,288
-636
-33% -$54.2K 0.04% 125
2019
Q4
$170K Buy
+1,924
New +$160K 0.09% 104

Other funds holding ABBV